PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 19, 2026Neuro-Oncology Advances2 citationsOpen Access

Tumor resection in glioblastoma mouse models: surgical techniques and translational potential

View Full Paper
JNJulie Van NieuwenhuyzeVIB-KU Leuven Center for Cancer BiologyAZAaron Ziani ZeryouhVIB-KU Leuven Center for Cancer BiologySVS. De VleeschauwerKU Leuven

Key Points

  • This review aims to analyze surgical resection techniques for glioblastoma in mouse models and their translational potential to human treatment.
  • Narrative review of 27 eligible studies
  • Categorization of resection methods: non-guided biopsy punch, non-guided freehand, fluorescence-guided, MRI-guided
  • Evaluation of feasibility and reproducibility of techniques
  • Non-guided techniques are simple but lack precision.
  • Fluorescence-guided techniques improve visualization but require expensive equipment.
  • MRI-guided strategies are rare and not used during surgery, affecting their applicability.

Abstract

Abstract Surgical resection is a cornerstone of glioblastoma (GBM) treatment in patients, yet it remains underrepresented in preclinical studies with mouse models. This narrative review analyzes the current resection techniques used in mouse GBM studies and evaluates their feasibility, reproducibility and translational relevance. A total of 27 eligible studies were included in the review and categorized by resection method: non-guided biopsy punch, non-guided freehand resection, fluorescence-guided freehand resection (using fluorescent cell lines or dyes), and magnetic resonance imaging (MRI) -guided approaches. While non-guided techniques (biopsy punch or freehand) are commonly employed due to their simplicity and affordability, they lack the precision and adaptability of more advanced methods. Fluorescence-guided resection improves tumor visualization but requires costly equipment and can introduce immunological biases. So-called MRI-guided strategies remain rare and MRI is not actually used intraoperatively. Despite technically challenging, GBM surgical resection in mice is feasible and several effective techniques are currently available. The systematic implementation of tumor resection in GBM preclinical studies could allow to more closely mimic the human scenario thereby improving the predictive value of GBM animal experiments.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Nieuwenhuyze et al. (2026) studied this question.

synapsesocial.com/papers/6996a77aecb39a600b3ed224https://doi.org/10.1093/noajnl/vdag044
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The Importance of Integrating Surgical Resection into Preclinical Glioblastoma Modeling2025 · 4 citations
  2. 2Combined Fluorescence-Guided Surgery with 5-Aminolevulinic Acid and Fluorescein in Glioblastoma: Technical Description and Report of 100 Cases2024 · 24 citations
  3. 3A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival2001 · 3,104 citations
  4. 4Developing Implantable Scaffolds to Enhance Neural Stem Cell Therapy for Post-Operative Glioblastoma2020 · 37 citations
  5. 5Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection2017 · 152 citations